Pfizer appoints Chris Boshoff as Chief Scientific Officer and President, Research & Development
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
He has 35+ years of experience in understanding of business and products, analytical ability, eye for detail and computer literacy and knowledge of recent trends.
He has more than 25 years of experience in manufacturing across various industries including petrochemicals, engineering polymers, agrochemicals, organic, and inorganic intermediates
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
He holds a Master’s in Management from the National University of Singapore
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
He has been associated with Caplin Steriles Ltd., Mylan Laboratories Ltd., Caplin Point Laboratories Ltd., Strides Arcolab Ltd. and Novartis Vaccines and Diagnostics
Konieczny has served as Interim CEO since April 2024
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Dhiraj brings 20+ years of extensive executive-level financial expertise across various industries including Pharma, Media, Retail, and FMCG
Birajeev is a seasoned Supply Chain leader with an experience of 23 years
Subscribe To Our Newsletter & Stay Updated